- Home
- HIHO vs ENSC Comparison
HIHO vs ENSC Comparison
Compare HIHO & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- ENSC
- Stock Information
- Founded
- HIHO 1990
- ENSC 2003
- Country
- HIHO Hong Kong
- ENSC United States
- Employees
- HIHO N/A
- ENSC N/A
- Industry
- HIHO Industrial Machinery/Components
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- ENSC Health Care
- Exchange
- HIHO Nasdaq
- ENSC Nasdaq
- Market Cap
- HIHO 8.2M
- ENSC 9.5M
- IPO Year
- HIHO 1996
- ENSC N/A
- Fundamental
- Price
- HIHO $1.93
- ENSC $0.59
- Analyst Decision
- HIHO
- ENSC
- Analyst Count
- HIHO 0
- ENSC 0
- Target Price
- HIHO N/A
- ENSC N/A
- AVG Volume (30 Days)
- HIHO 40.6K
- ENSC 45.0M
- Earning Date
- HIHO 10-10-2024
- ENSC 11-12-2024
- Dividend Yield
- HIHO 3.66%
- ENSC N/A
- EPS Growth
- HIHO N/A
- ENSC N/A
- EPS
- HIHO N/A
- ENSC N/A
- Revenue
- HIHO $7,648,000.00
- ENSC $4,421,404.00
- Revenue This Year
- HIHO N/A
- ENSC N/A
- Revenue Next Year
- HIHO N/A
- ENSC N/A
- P/E Ratio
- HIHO N/A
- ENSC N/A
- Revenue Growth
- HIHO 10.41
- ENSC 40.41
- 52 Week Low
- HIHO $1.70
- ENSC $0.14
- 52 Week High
- HIHO $2.88
- ENSC $2.06
- Technical
- Relative Strength Index (RSI)
- HIHO 47.27
- ENSC 53.54
- Support Level
- HIHO $1.89
- ENSC $0.62
- Resistance Level
- HIHO $2.08
- ENSC $0.74
- Average True Range (ATR)
- HIHO 0.06
- ENSC 0.11
- MACD
- HIHO -0.00
- ENSC -0.01
- Stochastic Oscillator
- HIHO 20.42
- ENSC 19.33
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.